📢 In line with @ThiemeGruppe@ThiemeIntl policy, T&H is transitioning away from X. 🔄
We remain committed to accuracy 📊transparency 🔍 & respectful scientific exchange 🤝 on our Bsky 🦋 and LinkedIn 💼accounts
Thanks to our amazing Social Media Editors 🙌✨
Links below⤵️
📢 In line with @ThiemeGruppe@ThiemeIntl policy, T&H is transitioning away from X. 🔄
We remain committed to accuracy 📊transparency 🔍 & respectful scientific exchange 🤝 on our Bsky 🦋 and LinkedIn 💼accounts
Thanks to our amazing Social Media Editors 🙌✨
Links below⤵️
📣 #Colchicine for the prevention and management of Atherosclerotic #Cardiovascular Disease ⬇️
📌 In this review, van Zelm and colleagues review the evidence for the use of colchicine in #ASCVD
🆓 on TH 👉 https://t.co/h3fAjaJLLR
#CardioEd#CAD#Cardiology
📣 Does #Anticoagulants with Angiogenesis Inhibitors Increase Bleeding in #Cancer? ⬇️
📌 In this network meta-analysis, Chen et al. found that adding anticoagulation to high-dose bevacizumab or antiangiogenic TKIs might increase #bleeding risk
Read 👉 https://t.co/g2Y2Si4ubU
📣 Tinzaparin Pharmacokinetics in Patients with Cancer⬇️
📌 Delavenne et al. report comparable PK profile in #cancer and non-cancer pts with Tinzaparin
📌 Further studies needed to clarify the role of renal function for dosing
👉 https://t.co/bSz9XxTI3q
#Thrombosis#Heparin
📣 Heavy Menstrual Bleeding in Women Treated with DOACs: Results of the HEMBLED Registry ⬇️
📌 Lindhoff-Last report differences among DOACs and their influence on the intensity of sponteneous menstrual bleeding
🆓 on TH: https://t.co/zePSrbdZ4Q
#Thrombosis#DOAC#VTE
📣 PCSK9 inhibition and platelet reactivity: pooled analysis of 2 RCTs ⬇️
📌 Ortega-Paz et al. investigated whether PCSK9 inhibition was associated with differences in platelet reactivity
Read on TH: https://t.co/65dszw5hY6
#Platelets#Thrombosis
👀 Read our interview 💬 with lead authors Katarina Glise Sandblad and Mazdak Tavoly on cause-specific #mortality in Pulmonary Embolism 🫁
Read article here ▶️ https://t.co/gSsXCydzTj
https://t.co/0uBfvw8MaK
📣 PCSK9 for prediction of adverse limb outcomes after endovascular #revascularization in diabetic chronic limb-threatening ischemia
📌 Biscetti et al. show higher #PCSK9 levels linked to increased major adverse limb events in diabetic pts
🆓 on TH: https://t.co/TlxXUrjEmO
🧠 Stroke in Mechanical Circulatory Supported Cardiogenic Shock ⬇️
📌 On #WorldStrokeDay, read this review from Galusko et al., on risk factors and mechanisms underlying stroke in patients receiving mechanical circulatory support
👉 https://t.co/3mizAn1nKx
#Stroke
VTE outcomes 🩺among cancer and non-cancer patients
Read our interview 💬with lead authors Robert McBane, Claire Cassianni and Waldemar Wysokinski.
Read Original article here https://t.co/878WwSf2WL
https://t.co/YizPhQhB8H
🫀 Factor XI levels and left atrial appendage thrombosis ⬇️
📌 Elevated Factor XI levels were linked to left atrial appendage thrombi of unknown origin, their recurrence, and higher risk of cerebrovascular events 🧠
Read 👉 https://t.co/WwKiEuCaPH
🧠 Participa en el proyecto europeo ARISTOTELES (@ARISTOTELES_HE), cuyo objetivo es evaluar el impacto de la #IA para definir trayectorias clínicas personalizadas y detectar precozmente patrones de comorbilidad y multimorbilidad en pacientes con #FibrilaciónAuricular.
🔗Encuestas abiertas para pacientes y profesionales:
📝Personal sanitario: https://t.co/7mhpLrC9zk
📝Pacientes y sociedad en general: https://t.co/VqlHNonam1
@JosemyRivera@vroldans_@UMU
PCSK9 and peripheral #vascular outcomes in #diabetic patients:
👀Read our #interview 💬with the lead authors Federico Biscetti @biscialoca, Maria Margherita Rando and Andrea Flex
Read full article here ➡️https://t.co/VrqAOKVCtp
https://t.co/DkLCDEdsIW
🩸 World Thrombosis Day is here!
Have research to share? We want to see it!
➡️ Submit your work to TH OPEN, the open-access companion journal of TH. 🔗 Submit here https://t.co/HATEBXqM5b
✨ Impact Factor 2024: 1.8